PT-141

PT-141 (Bremelanotide) 10mg is a synthetic peptide analog derived from alpha-melanocyte-stimulating hormone (α-MSH) that has been studied in research settings for its activity within melanocortin receptor signaling pathways, particularly those involved in central nervous system regulation. In simple terms, researchers use PT-141 to better understand how melanocortin signaling in the brain can influence neurological and …

$35.00

PT-141 (Bremelanotide) is a synthetic peptide analog derived from alpha-melanocyte-stimulating hormone (α-MSH) that has been studied in research settings for its activity within melanocortin receptor signaling pathways, particularly those involved in central nervous system regulation. In simple terms, researchers use PT-141 to better understand how melanocortin signaling in the brain can influence neurological and behavioral response pathways in controlled laboratory models.

From a technical standpoint, PT-141 is a cyclic heptapeptide that primarily acts as a non-selective agonist of melanocortin receptors, with significant activity at MC3R and MC4R subtypes within the central nervous system. Unlike related melanocortin compounds that primarily target peripheral pigmentation pathways, PT-141 is notable for its central (brain-mediated) receptor activity. This makes it a key compound in research exploring neuroendocrine signaling, hypothalamic regulation, and CNS melanocortin system function.

In preclinical and clinical research contexts, PT-141 is studied for its effects on central melanocortin pathways involved in behavioral signaling, autonomic nervous system regulation, and neuroendocrine communication. Its activity profile is distinct from peripheral melanocortin analogs due to its primary action within CNS receptor systems rather than pigment-related pathways.

PT-141 is intended strictly for laboratory research purposes only and is not approved for human consumption, medical use, or diagnostic applications.

Key Research Areas

  • Central melanocortin receptor (MC3R / MC4R) activation
  • Neuroendocrine signaling pathways
  • Hypothalamic CNS regulation studies
  • Autonomic nervous system signaling research
  • Melanocortin system behavioral pathway research

Chemical Information

  • Compound Name: PT-141 (Bremelanotide)
  • Type: Synthetic cyclic melanocortin peptide analog
  • Mechanism: Central melanocortin receptor agonist
  • Primary Activity Site: Central nervous system (MC3R/MC4R)
  • Research Focus: Neuroendocrine and CNS signaling pathways

Important Notice

This compound is sold strictly for laboratory research purposes only. It is not intended for human consumption, medical treatment, or diagnostic use. Proper handling and regulatory compliance are required by the purchaser.

Additional information